Literature DB >> 25624420

Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.

Doo Young Lee1, Jangsup Moon2, Soon-Tae Lee2, Keun-Hwa Jung2, Dong-Kyu Park1, Jung-Seok Yoo1, Jun-Sang Sunwoo2, Jung-Ick Byun2, Jung-Won Shin3, Daejong Jeon1, Ki-Young Jung2, Manho Kim4, Sang Kun Lee2, Kon Chu2.   

Abstract

With the recent advancement in transcriptome-wide profiling approach, numerous non-coding transcripts previously unknown have been identified. Among the non-coding transcripts, long non-coding RNAs (lncRNAs) have received increasing attention for their capacity to modulate transcriptional regulation. Although alterations in the expressions of non-coding RNAs have been studied in Alzheimer's disease (AD), most research focused on the involvement of microRNAs, and comprehensive expression profiling of lncRNAs in AD has been lacking. In this study, microarray analysis was performed to procure the expression profile of lncRNAs dysregulated in a triple transgenic model of AD (3xTg-AD). A total of 4,622 lncRNAs were analyzed: 205 lncRNAs were significantly dysregulated in 3xTg-AD compared with control mice, and 230 lncRNAs were significantly dysregulated within 3xTg-AD in an age-dependent manner (≥2.0-fold, p < 0.05). Among these, 27 and 15 lncRNAs, respectively, had adjacent protein-coding genes whose expressions were also significantly dysregulated. A majority of these lncRNAs and their adjacent genes shared the same direction of dysregulation. For these pairs of lncRNAs and adjacent genes, significant Gene Ontology terms were DNA-dependent regulation of transcription, transcription regulator activity, and embryonic organ morphogenesis. One of the most highly upregulated lncRNAs had a 395 bp core sequence that overlapped with multiple chromosomal regions. This is the first study that comprehensively identified dysregulated lncRNAs in 3xTg-AD mice and will likely facilitate the development of therapeutics targeting lncRNAs in AD.

Entities:  

Keywords:  3xTg-AD; Alzheimer's disease; gene ontology; long non-coding RNAs; microarray

Mesh:

Substances:

Year:  2015        PMID: 25624420     DOI: 10.3233/JAD-142919

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  27 in total

Review 1.  Noncoding RNAs in Alzheimer's disease.

Authors:  M Laura Idda; Rachel Munk; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-01-12       Impact factor: 9.957

Review 2.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

Review 3.  Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.

Authors:  Ke Li; Qing Wei; Fang-Fang Liu; Fan Hu; Ao-Ji Xie; Ling-Qiang Zhu; Dan Liu
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

4.  Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.

Authors:  Phoebe P Chum; Md A Hakim; Erik J Behringer
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 5.  Long noncoding RNAs: Central to nervous system development.

Authors:  Ronald P Hart; Loyal A Goff
Journal:  Int J Dev Neurosci       Date:  2016-06-11       Impact factor: 2.457

6.  Systematic analysis of the expression profile of non-coding RNAs involved in ischemia/reperfusion-induced acute kidney injury in mice using RNA sequencing.

Authors:  Jun Zhou; Hongtao Chen; Youling Fan
Journal:  Oncotarget       Date:  2017-10-26

7.  Altered Expression of the Long Noncoding RNA NEAT1 in Huntington's Disease.

Authors:  Jun-Sang Sunwoo; Soon-Tae Lee; Wooseok Im; Mijung Lee; Jung-Ick Byun; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Sang Kun Lee; Kon Chu; Manho Kim
Journal:  Mol Neurobiol       Date:  2016-05-25       Impact factor: 5.590

Review 8.  Alzheimer's Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target.

Authors:  Meng Zhang; Zhigang Bian
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

Review 9.  Insights into lncRNAs in Alzheimer's disease mechanisms.

Authors:  Dingfeng Li; Juan Zhang; Xiaohui Li; Yuhua Chen; Feng Yu; Qiang Liu
Journal:  RNA Biol       Date:  2020-07-14       Impact factor: 4.652

10.  Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese.

Authors:  Xiao-Long Chang; Lin Tan; Meng-Shan Tan; Hui-Fu Wang; Chen-Chen Tan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Zi-Xuan Wang; Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.